KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 104 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $29,201,000 | +64.4% | 387,741 | +9.4% | 0.26% | +73.0% |
| Q1 2015 | $17,766,000 | +79.0% | 354,265 | +23.8% | 0.15% | +46.5% |
| Q4 2014 | $9,927,000 | -2.6% | 286,255 | -8.0% | 0.10% | -21.1% |
| Q3 2014 | $10,197,000 | -14.6% | 311,255 | 0.0% | 0.13% | -12.3% |
| Q2 2014 | $11,943,000 | -3.5% | 311,255 | 0.0% | 0.15% | -7.0% |
| Q1 2014 | $12,375,000 | +5.8% | 311,255 | -0.6% | 0.16% | -4.8% |
| Q4 2013 | $11,698,000 | -3.2% | 313,191 | +18.2% | 0.16% | -4.1% |
| Q3 2013 | $12,081,000 | +170.7% | 265,000 | +60.6% | 0.17% | +95.5% |
| Q2 2013 | $4,463,000 | – | 165,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |